Proteinase-activated receptor 2 (PAR2) in hepatic stellate cells – evidence for a role in hepatocellular carcinoma growth in vivo
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Proteinase-activated receptor 2 (PAR2) in hepatic stellate cells – evidence for a role in hepatocellular carcinoma growth in vivo
Authors
Keywords
Proteinase-activated receptor 2, PAR<sub>2</sub>, Hepatocellular carcinoma, HCC, Hepatic stellate cells, HSCs, LX-2, Cell migration, Receptor tyrosine kinase, Met, Src, HCC xenograft, Angiogenesis
Journal
Molecular Cancer
Volume 15, Issue 1, Pages -
Publisher
Springer Nature
Online
2016-07-29
DOI
10.1186/s12943-016-0538-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Proteinase-activated receptor 2 promotes TGF-β-dependent cell motility in pancreatic cancer cells by sustaining expression of the TGF-β type I receptor ALK5
- (2016) Franziska Zeeh et al. Oncotarget
- Hepatic stellate cells: central modulators of hepatic carcinogenesis
- (2015) Alexandra I Thompson et al. BMC GASTROENTEROLOGY
- Global Epidemiology of Hepatocellular Carcinoma
- (2015) Katherine A. McGlynn et al. Clinics in Liver Disease
- Protective effects of hepatic stellate cells against cisplatin-induced apoptosis in human hepatoma G2 cells
- (2015) LEI ZHANG et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Protease-activated receptor-2 modulates hepatic stellate cell collagen release and apoptotic status
- (2014) Jiang-lin Li et al. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
- Activated Human Hepatic Stellate Cells Promote Growth of Human Hepatocellular Carcinoma in a Subcutaneous Xenograft Nude Mouse Model
- (2014) Zhi-min Geng et al. CELL BIOCHEMISTRY AND BIOPHYSICS
- Blockade of CD47-mediated cathepsin S/protease-activated receptor 2 signaling provides a therapeutic target for hepatocellular carcinoma
- (2014) Terence Kin-Wah Lee et al. HEPATOLOGY
- Role of activated hepatic stellate cells in proliferation and metastasis of hepatocellular carcinoma
- (2014) Nan Lin et al. HEPATOLOGY RESEARCH
- Tryptase inhibitor APC 366 prevents hepatic fibrosis by inhibiting collagen synthesis induced by tryptase/protease-activated receptor 2 interactions in hepatic stellate cells
- (2014) Jing Lu et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Stellate cells and the development of liver cancer: Therapeutic potential of targeting the stroma
- (2014) Cédric Coulouarn et al. JOURNAL OF HEPATOLOGY
- Protease-activated receptor 2 suppresses lymphangiogenesis and subsequent lymph node metastasis in a murine pancreatic cancer model
- (2014) Kun Shi et al. JOURNAL OF PATHOLOGY
- Hepatic stellate cells and extracellular matrix in hepatocellular carcinoma: more complicated than ever
- (2014) Vinicio Carloni et al. LIVER INTERNATIONAL
- Role of protease-activated receptors for the innate immune response of the heart
- (2014) Alice Weithauser et al. TRENDS IN CARDIOVASCULAR MEDICINE
- Hepatic stellate cells promote tumor progression by enhancement of immunosuppressive cells in an orthotopic liver tumor mouse model
- (2013) Wenxiu Zhao et al. LABORATORY INVESTIGATION
- Activation of TGF-β1 Promoter by Hepatitis C Virus-Induced AP-1 and Sp1: Role of TGF-β1 in Hepatic Stellate Cell Activation and Invasion
- (2013) Lance D. Presser et al. PLoS One
- Novel Strategies for Hepatocellular Carcinoma Based on MMPs Science
- (2012) Isao Okazaki et al. Anti-Cancer Agents in Medicinal Chemistry
- Elevated Serum IL-8 Is Associated with the Presence of Hepatocellular Carcinoma and Independently Predicts Survival
- (2012) Theodore H. Welling et al. CANCER INVESTIGATION
- Hepatocyte-Stellate Cell Cross-Talk in the Liver Engenders a Permissive Inflammatory Microenvironment That Drives Progression in Hepatocellular Carcinoma
- (2012) C. Coulouarn et al. CANCER RESEARCH
- Proteinase-activated receptor 2 (PAR2) in cholangiocarcinoma (CCA) cells: effects on signaling and cellular level
- (2012) Roland Kaufmann et al. HISTOCHEMISTRY AND CELL BIOLOGY
- Targeting proteinase-activated receptors: therapeutic potential and challenges
- (2012) Rithwik Ramachandran et al. NATURE REVIEWS DRUG DISCOVERY
- The role of the myofibroblast in tumor stroma remodeling
- (2012) Marcela Otranto et al. Cell Adhesion & Migration
- Modulating human proteinase activated receptor 2 with a novel antagonist (GB88) and agonist (GB110)
- (2011) JY Suen et al. BRITISH JOURNAL OF PHARMACOLOGY
- Protease-activated receptor 2 promotes experimental liver fibrosis in mice and activates human hepatic stellate cells
- (2011) Virginia Knight et al. HEPATOLOGY
- Activated hepatic stellate cells promote hepatocellular carcinoma development in immunocompetent mice
- (2011) Wenxiu Zhao et al. INTERNATIONAL JOURNAL OF CANCER
- Correction: Identifying and Characterizing Nodes Important to Community Structure Using the Spectrum of the Graph
- (2011) Yang Wang et al. PLoS One
- Oncogenic epidermal growth factor receptor up-regulates multiple elements of the tissue factor signaling pathway in human glioma cells
- (2010) N. Magnus et al. BLOOD
- Cooperation of tissue factor cytoplasmic domain and PAR2 signaling in breast cancer development
- (2010) F. Schaffner et al. BLOOD
- Proteinase-activated receptor 2-mediated calcium signaling in hepatocellular carcinoma cells
- (2010) Roland Kaufmann et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Activated hepatic stellate cells promote tumorigenicity of hepatocellular carcinoma
- (2009) Thomas Amann et al. CANCER SCIENCE
- Met receptor tyrosine kinase transactivation is involved in proteinase-activated receptor-2-mediated hepatocellular carcinoma cell invasion
- (2009) R. Kaufmann et al. CARCINOGENESIS
- The coagulation factor Xa/protease activated receptor-2 axis in the progression of liver fibrosis: a multifaceted paradigm
- (2009) Keren Borensztajn et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Role of Matriptase and Proteinase-Activated Receptor-2 in Nonmelanoma Skin Cancer
- (2009) Georgeta Bocheva et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Sorafenib for the Treatment of Unresectable Hepatocellular Carcinoma
- (2009) R. C. Kane et al. ONCOLOGIST
- Protease Activated Receptor Signaling Is Required for African Trypanosome Traversal of Human Brain Microvascular Endothelial Cells
- (2009) Dennis J. Grab et al. PLoS Neglected Tropical Diseases
- Protease-Activated Receptor (PAR) 2, but not PAR1, Signaling Promotes the Development of Mammary Adenocarcinoma in Polyoma Middle T Mice
- (2008) H. H. Versteeg et al. CANCER RESEARCH
- The Interleukin-8 Pathway in Cancer
- (2008) D. J.J. Waugh et al. CLINICAL CANCER RESEARCH
- Cowhage-Evoked Itch Is Mediated by a Novel Cysteine Protease: A Ligand of Protease-Activated Receptors
- (2008) V. B. Reddy et al. JOURNAL OF NEUROSCIENCE
- Derivatized 2-Furoyl-LIGRLO-amide, a Versatile and Selective Probe for Proteinase-Activated Receptor 2: Binding and Visualization
- (2008) M. D. Hollenberg et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial
- (2008) Ann-Lii Cheng et al. LANCET ONCOLOGY
- Sorafenib in Advanced Hepatocellular Carcinoma
- (2008) Josep M. Llovet et al. NEW ENGLAND JOURNAL OF MEDICINE
- Regulation of Actin Assembly Associated With Protrusion and Adhesion in Cell Migration
- (2008) Christophe Le Clainche et al. PHYSIOLOGICAL REVIEWS
- Hepatic Stellate Cells: Protean, Multifunctional, and Enigmatic Cells of the Liver
- (2008) Scott L. Friedman PHYSIOLOGICAL REVIEWS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now